An overview of hepatocellular carcinoma after insufficient radiofrequency ablation
Y Guo, Y Ren, X Dong, X Kan… - Journal of Hepatocellular …, 2022 - Taylor & Francis
Radiofrequency ablation (RFA) is a commonly used treatment for hepatocellular carcinoma
(HCC), however, various complex conditions in clinical practice may lead to insufficient …
(HCC), however, various complex conditions in clinical practice may lead to insufficient …
Radiofrequency ablation versus repeat resection for recurrent hepatocellular carcinoma (≤ 5 cm) after initial curative resection
Y Feng, H Wu, DQ Huang, C Xu, H Zheng, M Maeda… - European …, 2020 - Springer
Objectives Recurrence rate is up to 70% at 5 years for hepatocellular carcinoma (HCC) after
initial resection, but the management of recurrent HCC remains unclear. To compare the …
initial resection, but the management of recurrent HCC remains unclear. To compare the …
Multidisciplinary Treatment of Hepatocellular Carcinoma in 2023: Italian practice Treatment Guidelines of the Italian Association for the Study of the Liver (AISF), Italian …
G Cabibbo, B Daniele, M Borzio… - Digestive and Liver …, 2024 - Elsevier
Worldwide, hepatocellular carcinoma (HCC) is the third most common cause of cancer-
related death. The remarkable improvements in treating HCC achieved in the last years …
related death. The remarkable improvements in treating HCC achieved in the last years …
Radiofrequency ablation versus microwave ablation for early stage hepatocellular carcinoma: A PRISMA-compliant systematic review and meta-analysis
J Han, Y Fan, K Wang - Medicine, 2020 - journals.lww.com
Background: Several randomized control trials (RCTs) were conducted to compare
microwave ablation (MWA) and radiofrequency ablation (RFA) in the treatment of …
microwave ablation (MWA) and radiofrequency ablation (RFA) in the treatment of …
[PDF][PDF] 肝动脉灌注化疗栓塞联合射频消融治疗中晚期肝癌的疗效分析
张浩， 仲富瑞， 程宦立， 张婷， 夏先明 - 中国普通外科杂志, 2020 - zpwz.net
摘要背景与目的: 肝动脉灌注化疗栓塞术(TACE) 是治疗中晚期肝细胞癌(HCC) 的重要手段,
为进一步提高中晚期HCC 的治疗效果, TACE 联合射频消融术(RFA) 的方案也被用于临床 …
为进一步提高中晚期HCC 的治疗效果, TACE 联合射频消融术(RFA) 的方案也被用于临床 …
The safety and efficacy of nanosecond pulsed electric field in patients with hepatocellular carcinoma: a prospective phase 1 clinical study protocol
M Xu, D Xu, G Dong, Z Ren, W Zhang, T Aji… - Frontiers in …, 2022 - frontiersin.org
Background Hepatocellular carcinoma (HCC) is a highly aggressive malignancy.
Irreversible electroporation (IRE) is an ablative modality that uses high-voltage electrical …
Irreversible electroporation (IRE) is an ablative modality that uses high-voltage electrical …
ATPase inhibitory factor 1 promotes hepatocellular carcinoma progression after insufficient radiofrequency ablation, and attenuates cell sensitivity to sorafenib therapy
J Kong, C Yao, X Ding, S Dong, S Wu, W Sun… - Frontiers in …, 2020 - frontiersin.org
Epithelial-mesenchymal transition (EMT) and angiogenesis is involved in tumor progression
after radiofrequency ablation (RFA). ATPase inhibitory factor 1 (IF1) is a bad predictor of …
after radiofrequency ablation (RFA). ATPase inhibitory factor 1 (IF1) is a bad predictor of …
Experience with changing etiology and nontransplant curative treatment modalities for hepatocellular carcinoma in a real-life setting—a retrospective descriptive …
Background Hepatocellular carcinoma (HCC) has variable etiological risk factors.
Radiofrequency ablation (RFA) and surgical resection (SR) are frequently used as curative …
Radiofrequency ablation (RFA) and surgical resection (SR) are frequently used as curative …
Amarogentin Inhibits Liver Cancer Cell Angiogenesis after Insufficient Radiofrequency Ablation via Affecting Stemness and the p53‐Dependent VEGFA/Dll4/Notch1 …
Y Zhang, Y Zhang, J Wang, H Gu - BioMed Research …, 2020 - Wiley Online Library
Background. Whether and how amarogentin suppresses the angiogenesis effect in liver
cancer cells after insufficient radiofrequency ablation (iRFA) are still poorly studied …
cancer cells after insufficient radiofrequency ablation (iRFA) are still poorly studied …
Surgical resection vs. percutaneous ablation for single hepatocellular carcinoma: exploring the impact of Li-RADS classification on oncological outcomes
Simple Summary Li-RADS classification has recently emerged as an accurate tool for
hepatocellular carcinoma diagnosis in the setting of liver cirrhosis, but its prognostic value …
hepatocellular carcinoma diagnosis in the setting of liver cirrhosis, but its prognostic value …